Safety and activity of sunitinib in elderly patients (≥ 70 years) with metastatic renal cell carcinoma: a multicenter study.
about
Expert Recommendations for First-Line Management of Metastatic Renal Cell Carcinoma in Special Subpopulations.Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical Practice.Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity.Protein kinase inhibitors in renal cell carcinoma.Treatment of elderly patients with metastatic renal cell carcinoma.Role of dose exposure and inflammatory status in a single center, real-world analysis of sunitinib in patients with metastatic renal cell carcinoma.Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis.Efficacy and safety of axitinib in elderly patients with metastatic renal cell carcinoma.Activity and safety of sunitinib in poor risk metastatic renal cell carcinoma patients.First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel–Lindau (VHL) disease: clinical outcome and patterns of radiological response
P2860
Q30382892-7538BA01-9641-4E76-9BCE-633BB11FA457Q31122505-1C927DF1-35DD-4100-8864-813E4FA8874AQ38155199-045B3602-39BC-4BE4-8915-B30AE92881C0Q38170411-89103E8E-1E2D-4374-8619-CCFAE3465471Q38665322-49F6069F-A389-4766-9318-341118219EB0Q38907399-A7CEDB51-B602-465C-A488-C1E5A23DC591Q47151156-BF9B7EBF-A0E9-42E2-94E1-473ED48941FEQ47692080-A6776F1A-AC30-47CF-9F50-608D98F71AFAQ53630353-5E635A91-701D-4943-90CA-86C52141EB2FQ57578654-58C3EDE2-CB20-4883-8E42-A8F7A0CD9765
P2860
Safety and activity of sunitinib in elderly patients (≥ 70 years) with metastatic renal cell carcinoma: a multicenter study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Safety and activity of sunitin ...... arcinoma: a multicenter study.
@en
Safety and activity of sunitinib in elderly patients
@nl
type
label
Safety and activity of sunitin ...... arcinoma: a multicenter study.
@en
Safety and activity of sunitinib in elderly patients
@nl
prefLabel
Safety and activity of sunitin ...... arcinoma: a multicenter study.
@en
Safety and activity of sunitinib in elderly patients
@nl
P2093
P2860
P50
P356
P1433
P1476
Safety and activity of sunitin ...... carcinoma: a multicenter study
@en
P2093
A Camerini
P2860
P304
P356
10.1093/ANNONC/MDS431
P577
2012-10-09T00:00:00Z